|
1
|
Venkatesh K, Lamba Saini M, Niveditha SR,
Krishnagiri C and Babu S: Primary leiomyosarcoma of the kidney.
Patholog Res Int. 2010:6523982010.PubMed/NCBI
|
|
2
|
Lalwani N, Prasad SR, Vikram R, et al:
Pediatric and adult primary sarcomas of the kidney: a
cross-sectional imaging review. Acta Radiol. 52:448–457. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valery JR, Tan W and Cortese C: Renal
leiomyosarcoma: a diagnostic challenge. Case Rep Oncol Med.
2013:4592822013.PubMed/NCBI
|
|
4
|
Lee G, Lee SY, Seo S, et al: Prognostic
factors and clinical outcomes of urological soft tissue sarcomas.
Korean J Urol. 52:669–673. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Edge SB, Byrd DR, Compton CC, et al: Soft
tissue sarcoma. AJCC Cancer Staging Manual. 7th edition. Springer;
New York, NY: pp. 291–296. 2010
|
|
6
|
Guillou L, Coindre JM, Bonichon F, et al:
Comparative study of the National Cancer Institute and French
Federation of Cancer Centers Sarcoma Group grading systems in a
population of 410 adult patients with soft tissue sarcoma. J Clin
Oncol. 15:350–362. 1997.PubMed/NCBI
|
|
7
|
Lewis JJ, Leung D, Woodruff JM and Brennan
MF: Retroperitoneal soft-tissue sarcoma: analysis of 500 patients
treated and followed at a single institution. Ann Surg.
228:355–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Dalen T, Plooij JM, van Coevorden F,
et al: Dutch Soft Tissue Sarcoma Group: Long-term prognosis of
primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol.
33:234–238. 2007. View Article : Google Scholar
|
|
9
|
Singer S, Maki RG and O’Sullivan B: Soft
tissue sarcoma. Cancer: Principles and Practice of Oncology. DeVita
VT Jr, Lawrence TS and Rosenberg SA: 9th edition. Lippincott
Williams & Wilkins; Philadelphia, PA: pp. 1533–1577. 2011
|
|
10
|
Dotan ZA, Tal R, Golijanin D, et al: Adult
genitourinary sarcoma: the 25-year Memorial Sloan-Kettering
experience. J Urol. 176:2033–2038. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Geel AN, Pastorino U, Jauch KW, et al:
Surgical treatment of lung metastases: The European Organization
for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma
Group study of 255 patients. Cancer. 77:675–682. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Putnam JB Jr and Roth JA: Surgical
treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin
North Am. 9:869–887. 1995.PubMed/NCBI
|
|
13
|
Kadikoy H, Haque WM, Topkara VK, Frome AI
and Hayes TG: Bilateral leiomyosarcoma of the kidney with family
history of kidney cancer. Can J Urol. 16:4847–4849. 2009.PubMed/NCBI
|
|
14
|
Maki RG, Wathen JK, Patel SR, et al:
Randomized phase II study of gemcitabine and docetaxel compared
with gemcitabine alone in patients with metastatic soft tissue
sarcomas: results of sarcoma alliance for research through
collaboration study 002 [corrected]. J Clin Oncol. 25:2755–2763.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kepka L, DeLaney TF, Suit HD and Goldberg
SI: Results of radiation therapy for unresected soft-tissue
sarcomas. Int J Radiat Oncol Biol Phys. 63:852–859. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sarcoma Meta-analysis Collaboration
(SMAC). Adjuvant chemotherapy for localised resectable soft tissue
sarcoma in adults. Cochrane Database Syst Rev. CD0014192000.
|
|
17
|
Alvegård TA and Berg NO: Histopathology
peer review of high-grade soft tissue sarcoma: the Scandinavian
Sarcoma Group experience. J Clin Oncol. 7:1845–1851.
1989.PubMed/NCBI
|
|
18
|
Deyrup AT, Montgomery E and Fisher C:
Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg
Pathol. 28:178–182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singer S, Nielsen T and Antonescu CR:
Molecular biology of soft tissue sarcoma. Cancer: Principles and
Practice of Oncology. DeVita VT Jr, Lawrence TS and Rosenberg SA:
9th edition. Lippincott Williams & Wilkins; Philadelphia, PA:
pp. 1522–1532. 2011
|
|
20
|
Mazeron JJ and Suit HD: Lymph nodes as
sites of metastases from sarcomas of soft tissue. Cancer.
60:1800–1808. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Watanabe N, Omagari D, Yamada T, et al:
Anaplastic sarcoma of the kidney: case report and literature
review. Pediatr Int. 55:e129–e132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iwasaki H, Fuse H and Imamura Y: Myeloid
sarcoma of the kidney: a case report. Nihon Hinyokika Gakkai
Zasshi. 103:708–711. 2012.(In Japanese).
|
|
23
|
Trolliet S, Lindner V, Krzisch S,
Schneider M and Jung JL: Primary renal synovial sarcoma. Prog Urol.
24:156–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karavasilis V, Seddon BM, Ashley S, et al:
Significant clinical benefit of first-line palliative chemotherapy
in advanced soft-tissue sarcoma: retrospective analysis and
identification of prognostic factors in 488 patients. Cancer.
112:1585–1591. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ellinger J, Bastian PJ, Hauser S, Biermann
K and Müller SC: Primitive neuroectodermal tumor: rare, highly
aggressive differential diagnosis in urologic malignancies.
Urology. 68:257–262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Angel JR, Alfred A, Sakhuja A, et al:
Ewing’s sarcoma of the kidney. Int J Clin Oncol. 15:314–318. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ekram T, Elsayes KM, Cohan RH and Francis
IR: Computed tomography and magnetic resonance features of renal
Ewing sarcoma. Acta Radiol. 49:1085–1090. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Liu B, Song N, et al:
Interdigitating dendritic cell sarcoma presenting in the kidney
combined with retroperitoneal leiomyosarcoma: A case report and
literature review. Oncol Lett. 7:466–470. 2014.PubMed/NCBI
|
|
29
|
Nayer H, Murphy KM, Hawkins AL, et al:
Clonal cytogenetic abnormalities and BCL2 rearrangement in
interdigitating dendritic cell sarcoma. Leuk Lymphoma.
47:2651–2654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mehrain R and Nabahati M: A case of
rhabdomyosarcoma of kidney mimicking nephroblastoma. Caspian J
Intern Med. 4:621–623. 2013.PubMed/NCBI
|
|
31
|
Miettinen M: Smooth muscle tumors of soft
tissue and non-uterine viscera: biology and prognosis. Mod Pathol.
27(Suppl 1): S17–S29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hakverdi S, Güngören A, Yaldiz M, Hakverdi
AU and Toprak S: Immunohistochemical analysis of p16 expression in
uterine smooth muscle tumors. Eur J Gynaecol Oncol. 32:513–515.
2011.PubMed/NCBI
|
|
33
|
Schwetye KE, Pfeifer JD and Duncavage EJ:
MED12 exon 2 mutations in uterine and extrauterine smooth muscle
tumors. Hum Pathol. 45:65–70. 2014. View Article : Google Scholar
|
|
34
|
Silveira SM, Villacis RA, Marchi FA, et
al: Genomic signatures predict poor outcome in undifferentiated
pleomorphic sarcomas and leiomyosarcomas. PLoS One. 8:e676432013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Badeloe S, van Geest AJ, van Marion AM and
Frank J: Absence of fumarate hydratase mutation in a family with
cutaneous leiomyosarcoma and renal cancer. Int J Dermatol. 47(Suppl
1): 18–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao LR, Tian W, Wang GW, Chen KX and Yang
JL: The prognostic role of PRUNE2 in leiomyosarcoma. Chin J Cancer.
32:648–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsiatis AC, Herceg ME, Keedy VL, et al:
Prognostic significance of c-Myc expression in soft tissue
leiomyosarcoma. Mod Pathol. 22:1432–1438. 2009. View Article : Google Scholar : PubMed/NCBI
|
